Yale University

Publications

Filters: Keyword is Narcotic Antagonists  [Clear All Filters]
2011
Korthuis, Todd P., David A. Fiellin, Rongwei Fu, Paula J. Lum, Frederick L. Altice, Nancy Sohler, Mary J. Tozzi, Steven M. Asch, Michael Botsko, Margaret Fishl et al. "Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S83-90. Abstract
Friedland, Gerald, and David Vlahov. "Integration of buprenorphine for substance-abuse treatment by HIV care providers." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S1-2.
Weiss, Linda, Julie Netherland, James E. Egan, Timothy P. Flanigan, David A. Fiellin, Ruth Finkelstein, and Frederick L. Altice. "Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
McCance-Katz, Elinore F., David E. Moody, Sudha Prathikanti, Gerald Friedland, and Petrie M. Rainey. "Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients." Drug and alcohol dependence 118, no. 2-3 (2011): 326-34. Abstract
2012
Barry, Declan T., Jonathan D. Savant, Mark Beitel, Christopher J. Cutter, Brent A. Moore, Richard S. Schottenfeld, and David A. Fiellin. "Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone." Journal of addiction medicine 6, no. 4 (2012): 274-9. Abstract
Tetrault, Jeanette M., Janet P. Tate, Kathleen A. McGinnis, Joseph L. Goulet, Lynn E. Sullivan, Kendall Bryant, Amy C. Justice, and David A. Fiellin. "Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone." Alcoholism, clinical and experimental research 36, no. 2 (2012): 318-24. Abstract
Tetrault, Jeanette M., and David A. Fiellin. "Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals." Drugs 72, no. 2 (2012): 217-28. Abstract
2013
Seewald, Randy, Douglas R. Bruce, Rashiah Elam, Ruy Tio, Sara Lorenz, Patricia Friedmann, David Rabin, Yana B. Garger, Valentin Bonilla, and David C. Perlman. "Effectiveness and feasibility study of routine HIV rapid testing in an urban methadone maintenance treatment program." The American journal of drug and alcohol abuse 39, no. 4 (2013): 247-51. Abstract
Davis, Corey, Damika Webb, and Scott Burris. "Changing law from barrier to facilitator of opioid overdose prevention." The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 41 Suppl 1 (2013): 33-6. Abstract
Edelman, Jennifer E., Brent A. Moore, Sarah Caffrey, Kathleen J. Sikkema, Emlyn S. Jones, Richard S. Schottenfeld, David A. Fiellin, and Lynn E. Fiellin. "HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment." Journal of addiction medicine 7, no. 6 (2013): 410-6. Abstract
2015
Fiellin, David A., Patrick G. O'Connor, and Gail D'Onofrio. "Opioid Dependence Treatment in the Emergency Department--Reply." JAMA 314, no. 8 (2015): 835.